Differences in isotretinoin start, interruption, and early termination across race and sex in the iPLEDGE era
Sign Up to like & getrecommendations! Published in 2019 at "PLoS ONE"
DOI: 10.1371/journal.pone.0210445
Abstract: Background iPLEDGE is the mandatory regulatory program for isotretinoin in the United States, aimed to prevent isotretinoin-related teratogenicity. However, little is known about potential unintended impact of the program, including delay in isotretinoin initiation, course… read more here.
Keywords: differences isotretinoin; start interruption; isotretinoin start; ipledge ... See more keywords